Unified digital thread connects R&D, quality, manufacturing, and supply chain to cut regulatory risk and delays.

Five new customers in Q2 and 13 in the first half of 2026 — including expansion and multi-year agreements with current customers — underscore Enlil's growth trajectory and leadership in MedTech ...

At the core of Enlil's offering is its use of AI-powered intelligence, including a private large language model (LLM)–driven chatbot. By embedding secure, contextual AI into its platform, Enlil's ...

Eight MedTech innovators, spanning organ perfusion, surgical robotics, Software as a Medical Device, AI-driven imaging, and more, chose Enlil's AI-powered traceability platform in Q1 2026, migrating ...

Newswise — CAMPBELL, Calif., March 4, 2025 - Enlil, Inc., a Shifamed portfolio company accelerating innovation for regulated product companies with its comprehensive development traceability platform, ...

Enlil was founded to solve a critical challenge for medical device innovators: efficiently navigating regulated product development without being hindered by disconnected systems, manual processes, or ...

Enlil, an AI-powered development traceability platform built for medical device organizations, recently announced the strongest revenue quarter in the company’s history. During the second quarter, ...

CAMPBELL, Calif., July 30, 2026 /PRNewswire/ -- Enlil, Inc., the AI-powered development traceability platform built for medical device and life sciences organizations, today announced the strongest ...